Medicare patients admitted to hospitals with higher readmission rates are more likely to have characteristics associated with a higher probability of readmission, according to a study published online today by JAMA Internal Medicine. “This finding suggests that Medicare is penalizing hospitals to a large extent based on the patients they serve,” the study concludes. The authors found 22 patient characteristics that significantly predicted readmission when added to standard Hospital Readmissions Reduction Program adjustments of hospital readmission rates, and 17 of these were distributed differently between hospitals in the highest and lowest quintiles of publicly reported readmission rates. For example, patients admitted to the highest quartile had more chronic conditions, less education, fewer assets, worse self-reported health status, more depressive symptoms, worse cognition and physical functioning, and more difficulties with daily living activities. The difference in readmission risk between hospitals in the highest and lowest quintiles fell by 48% after adjusting for all patient characteristics assessed. For more on the study, see today’s AHASTAT blog post.

Headline
March 8-14 marks Patient Safety Awareness Week. The AHA has several resources including podcasts, videos and reports that show how AHA members are advancing…
Headline
The U.S. District Court for the Southern District of Florida March 6 ruled in favor of five Florida hospitals in a case challenging the methodology used by the…
Chairperson's File
Public
This week, March 8-14, is Patient Safety Awareness Week. Delivering safe, quality care to all patients is the top priority for everyone working in hospitals…
Headline
The Food and Drug Administration has identified a Class I recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus…
Headline
Thomas McGinn, M.D., senior executive vice president and chief physician executive officer at CommonSpirit Health, shares how the organization aligns…
Headline
The Food and Drug Administration Feb. 3 released an early alert on a heart pump issue from certain Abiomed products. The agency said Abiomed found its Impella…